Concepedia

Matthias D’Huyvetter

MD

32

Publications

2.1K

Citations

22

H-Index

2012

Active since

Affiliations

Vrije Universiteit Brussel(Current)

Universitair Ziekenhuis Brussel

Belgian Nuclear Research Centre

Joint Research Centre

Vlaams Instituut voor Biotechnologie

Matthias D’Huyvetter is an author at Vrije Universiteit Brussel specializing in radiation oncology, tumor biology, and medicine.

ORCID

Top concepts

Publications per year

2012–2024

32

Publications

32

Synthesis, Preclinical Validation, Dosimetry, and Toxicity of <sup>68</sup>Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer

Catarina Xavier, Ilse Vaneycken, Matthias D’Huyvetter et al. · Journal of Nuclear Medicine · 2013 · 219 citations · Full text

Targeted Radionuclide Therapy with A <sup>177</sup>Lu-labeled Anti-HER2 Nanobody

Matthias D’Huyvetter, Cécile Vincke, Catarina Xavier et al. · Theranostics · 2014 · 214 citations · Full text

Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours

Pieterjan Debie, Chrystel Lafont, Michel Defrise et al. · Journal of Controlled Release · 2019 · 181 citations · Full text

131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

Matthias D’Huyvetter, Jens De Vos, Catarina Xavier et al. · Clinical Cancer Research · 2017 · 173 citations · Full text

PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using <sup>18</sup>F-Radiolabeled Camelid Single-Domain Antibody Fragments

Anneleen Blykers, Steve Schoonooghe, Catarina Xavier et al. · Journal of Nuclear Medicine · 2015 · 153 citations · Full text

Rows per page

1–5 of 32